Age-dependent use of alternative cerebral substrates during metabolic depression

代谢性抑郁症期间替代性脑基质的年龄依赖性使用

基本信息

项目摘要

The acute metabolic changes after traumatic brain injury (TBI) are defined by the indiscriminate release of potassium and glutamate, transient elevation in local cerebral metabolic rate of glucose followed by prolonged glucose metabolic depression and reduction of ATP. During this period of depressed glucose metabolism there is an increase flux of glucose through the pentose phosphate, free radical production and activation of poly ADP-ribose polymerase (PARP) via DMA damage. The PARP-mediated DMA repair process requires NAD+. Depletion of the cytosolic NAD+ pool has been shown to decrease GAPDH (a key enzyme in the glycolytic pathway) activity. Under conditions of impaired glycolytic metabolism, glucose becomes a less favorable energy substrate. While glucose remains the primary cerebral metabolic substrate under normal conditions, there are many physiological states during which the brain's reliance on glucose shifts towards ketone bodies, which are the only endogenously circulating alternative substrate that can significantly supplement cerebral metabolism. Recently, we have shown that exogenously administered R>- hydroxybutyrate is metabolized by the adult brain and TBI-induced decrease in ATP is alleviated (Prins et al., 2004). Our laboratory has also demonstrated the effectiveness of the ketogenic diet in reducing cortical contusion volume by 50% following focal TBI among postnatal day 30 (PND30) and PND45 rats (Prins et al 2005). The potential to utilize ketones as an alternative substrate decreases with cerebral maturation, suggesting that the younger brain possesses a greater ability to metabolize this substrate. The central hypothesis of this project is that TBI-induced changes in substrate transport and glucose biochemical processing promote age-dependent metabolism of alternative substrates during CMRglc depression. We believe that the use of ketone bodies as an alternative cerebral metabolic substrate offers exciting therapeutic potential following focal TBI in the developing brain and offers desperately needed treatment options for children with TBI.
创伤性脑损伤(TBI)后的急性代谢变化定义为不分青红皂白地释放 钾和谷氨酸,脑局部葡萄糖代谢率一过性升高,随后 长期糖代谢抑制和三磷酸腺苷减少。在这段血糖低迷的时期 新陈代谢通过磷酸戊糖、自由基的产生和葡萄糖流量的增加 通过DMA损伤激活多聚ADP-核糖聚合酶(PARP)。PARP介导的DMA修复 进程需要NAD+。胞浆NAD+池的耗尽已被证明降低了GAPDH(一个关键的 糖酵解途径中的酶)活性。在糖酵解代谢受损的情况下,葡萄糖 成为一种不那么有利的能量底物。而葡萄糖仍然是大脑的主要代谢底物 在正常情况下,大脑有许多生理状态,在此期间大脑对葡萄糖的依赖 向酮体转移,酮体是唯一内源循环的替代底物,可以 显著补充大脑新陈代谢。最近,我们已经证明,外源性给药的R>- 羟丁酸是由成人大脑代谢的,脑损伤导致的三磷酸腺苷下降得到缓解(Prins等人, 2004年)。我们的实验室还证明了生酮饮食在减少皮质醇含量方面的有效性。 出生后30天(PND30)和PND45的大鼠局灶性脑损伤后50%的挫伤体积(Prins等人 2005)。利用酮作为替代底物的可能性随着大脑的成熟而降低, 这表明较年轻的大脑具有更强的代谢这种底物的能力。中环 本项目的假设是脑损伤引起底物转运和葡萄糖生化的变化。 在CMRglc抑郁期间,加工促进替代底物的年龄相关新陈代谢。我们 相信使用酮体作为大脑代谢的替代底物提供了令人兴奋的 大脑发育中的局灶性脑损伤后的治疗潜力和迫切需要的治疗 创伤性脑损伤儿童的选择。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mayumi Lynn Prins其他文献

Mayumi Lynn Prins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mayumi Lynn Prins', 18)}}的其他基金

Timing Of Exercise In Concussed Rat Athletes
脑震荡大鼠运动员的运动时机
  • 批准号:
    10576291
  • 财政年份:
    2019
  • 资助金额:
    $ 19.52万
  • 项目类别:
Cerebral Substrate Support After Traumatic Brain Injury
脑外伤后的脑基质支持
  • 批准号:
    10447053
  • 财政年份:
    2018
  • 资助金额:
    $ 19.52万
  • 项目类别:
Cerebral Substrate Support After Traumatic Brain Injury
脑外伤后的脑基质支持
  • 批准号:
    10199063
  • 财政年份:
    2018
  • 资助金额:
    $ 19.52万
  • 项目类别:
Cerebral Substrate Support After Traumatic Brain Injury
脑外伤后的脑基质支持
  • 批准号:
    9788536
  • 财政年份:
    2018
  • 资助金额:
    $ 19.52万
  • 项目类别:
Age-Dependent Ketone Metabolism After Brain Injury
脑损伤后年龄依赖性酮代谢
  • 批准号:
    7076205
  • 财政年份:
    2005
  • 资助金额:
    $ 19.52万
  • 项目类别:
Age-Dependent Ketone Metabolism After Brain Injury
脑损伤后年龄依赖性酮代谢
  • 批准号:
    7254100
  • 财政年份:
    2005
  • 资助金额:
    $ 19.52万
  • 项目类别:
Age-Dependent Ketone Metabolism After Brain Injury
脑损伤后年龄依赖性酮代谢
  • 批准号:
    6958787
  • 财政年份:
    2005
  • 资助金额:
    $ 19.52万
  • 项目类别:
Age-dependent use of alternative cerebral substrates during metabolic depression
代谢性抑郁症期间替代性脑基质的年龄依赖性使用
  • 批准号:
    8376070
  • 财政年份:
  • 资助金额:
    $ 19.52万
  • 项目类别:
Age-dependent use of alternative cerebral substrates during metabolic depression
代谢性抑郁症期间替代性脑基质的年龄依赖性使用
  • 批准号:
    8043503
  • 财政年份:
  • 资助金额:
    $ 19.52万
  • 项目类别:
Age-dependent use of alternative cerebral substrates during metabolic depression
代谢性抑郁症期间替代性脑基质的年龄依赖性使用
  • 批准号:
    7663688
  • 财政年份:
  • 资助金额:
    $ 19.52万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.52万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.52万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 19.52万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.52万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 19.52万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.52万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.52万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.52万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 19.52万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 19.52万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了